Cargando…

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent

PURPOSE: The optimal time from surgery to initiation of adjuvant chemotherapy of breast cancer is still controversial. We investigated the influence of time to adjuvant chemotherapy on survival outcomes according to breast cancer subtype. RESULTS: Longer delay of initiation of adjuvant chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ke-Da, Fan, Lei, Qiu, Li-Xin, Ling, Hong, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542291/ https://www.ncbi.nlm.nih.gov/pubmed/27447963 http://dx.doi.org/10.18632/oncotarget.10551

Ejemplares similares

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis
por: Yu, Ke-Da, et al.
Publicado: (2013)

Interaction between glutathione S‐transferase M1‐null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer
por: Li, Shuang, et al.
Publicado: (2018)

Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
por: Ashok Kumar, Prashanth, et al.
Publicado: (2021)

Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma
por: Guo, Rui, et al.
Publicado: (2016)

Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
por: Zarcos‐Pedrinaci, Irene, et al.
Publicado: (2019)

Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
por: Castillo, Cecilia, et al.
Publicado: (2021)

Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstruction
por: Huttunen, Tuomas, et al.
Publicado: (2022)

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
por: Jiménez Fonseca, Paula, et al.
Publicado: (2017)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
por: Morris, M, et al.
Publicado: (2007)

The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study
por: Kim, Young Wan, et al.
Publicado: (2017)

High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients
por: Zhu, Li, et al.
Publicado: (2020)

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
por: Kümmel, S, et al.
Publicado: (2006)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy
por: Gómez, Rodolfo, et al.
Publicado: (2015)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
por: Simpson, G. S., et al.
Publicado: (2014)

Association between weight gain during adjuvant chemotherapy for early‐stage breast cancer and survival outcomes
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC
por: Tasoulas, Jason, et al.
Publicado: (2021)

Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype
por: Yu, Ke-Da, et al.
Publicado: (2015)

Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis
por: Zhang, Yu-fei, et al.
Publicado: (2022)

The influence of breast cancer subtype on survival after palliative radiation for osseous metastases
por: Abdelhakiem, Mohamed K., et al.
Publicado: (2020)

Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better?
por: Chen, Qi-Yue, et al.
Publicado: (2020)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?
por: Liu, Yutao, et al.
Publicado: (2017)

Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
por: Wang, Yun, et al.
Publicado: (2016)

Early versus delayed initiation of adjuvant treatment for pancreatic cancer
por: Kim, Hyoung Woo, et al.
Publicado: (2017)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
por: Kolla, Bhaskar C., et al.
Publicado: (2020)

Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2019)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
por: Xu, Hui, et al.
Publicado: (2020)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

Relationship between initiation time of adjuvant chemotherapy and survival in ovarian cancer patients: a dose-response meta-analysis of cohort studies
por: Liu, Yi, et al.
Publicado: (2017)

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab
por: Marushima, Hideki, et al.
Publicado: (2020)

Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis
por: Zhan, Qiao-Hui, et al.
Publicado: (2017)

Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
por: Flores-Balcázar, Christian H, et al.
Publicado: (2018)

Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients
por: Leonard, R C F, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vcngqf3f7ettnl7esdbp2p98sg